tirzepatide in westlake Skinny Shot Westlake, TX Medical Weight Loss Treatments |

The rest of their 2026 development pipeline is essentially barebones, stuck in phase 1/phase 2

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (736 amide) in type 2 (non-insulin-dependent) diabetic patients

The intermediate dose

SURMOUNT-1 Trial (New England Journal of Medicine, 2022) Randomized, double-blind, placebo-controlled 2,539 participants 72 weeks NCT04184622 Tirzepatide 5 mg -16.0% Mean body weight reduction Tirzepatide 10 mg -21.4% Mean body weight reduction Tirzepatide 15 mg -22.5% Mean body weight reduction Placebo group: -2.4% All results statistically significant (p 27 with Comorbidities Overweight or obese patients (Indian cutoff BMI 23+ with risk factors) seeking significant, sustained weight loss

Published trial data reflects brand-name medications in controlled conditions - not proof of compounded-product outcomes from any specific telehealth program

Preclinical research shows tirzepatide attenuates dopamine reward signaling and dose-dependently reduces voluntary alcohol consumption in rodent models